Targeted Medical Pharma, Inc.
TRGM
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Net Income | -144.53% | 56.47% | 67.46% | -13.14% | -46.33% |
| Total Depreciation and Amortization | 3.28% | -9.94% | -14.92% | -30.78% | -1.61% |
| Total Amortization of Deferred Charges | 0.00% | -7.08% | 21.53% | 0.00% | -36.80% |
| Total Other Non-Cash Items | 537.41% | 42.24% | -266.67% | -82.51% | -27.22% |
| Change in Net Operating Assets | 51.06% | -37.96% | 887.03% | -96.92% | 84.12% |
| Cash from Operations | -42.13% | 609.59% | 98.23% | -714.81% | 26.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Investing | -- | -- | 200.00% | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | 13.91% | 26.07% | -3.93% | 35.05% | 12.08% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 89.10% | 26.07% | -110.73% | 729.23% | -53.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7,850.00% | 99.62% | -195.46% | 834.03% | -287.01% |
